893
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Making rabies prophylaxis more economical

Immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers

, , , , , , , , , & show all
Pages 114-119 | Received 16 May 2013, Accepted 24 Aug 2013, Published online: 05 Sep 2013

References

  • WHO Publication. Rabies vaccines: WHO position paper--recommendations. Vaccine 2010; 28:7140 - 2; http://dx.doi.org/10.1016/j.vaccine.2010.08.082; PMID: 20831913
  • Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD. Epidemiological investigations of human rabies in China. BMC Infect Dis 2009; 9:210; http://dx.doi.org/10.1186/1471-2334-9-210; PMID: 20025742
  • WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser 2005; 931:1 - 88; PMID: 16485446
  • [In Editor.] China Rabies Control Situation. China Animal Husbandry and Veterinary Medicine 2009; 36:144 - 6
  • Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585 - 621; http://dx.doi.org/10.1016/0014-4827(61)90192-6; PMID: 13905658
  • Vodopija I, Sureau P, Lafon M, Baklaic Z, Ljubicić M, Svjetlicić M, Smerdel S. An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule. Vaccine 1986; 4:245 - 8; http://dx.doi.org/10.1016/0264-410X(86)90138-6; PMID: 3541428
  • Vodopija I. Current issues in human rabies immunization. Rev Infect Dis 1988; 10:Suppl 4 S758 - 63; http://dx.doi.org/10.1093/clinids/10.Supplement_4.S758; PMID: 3060962
  • Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Bull World Health Organ 1998; 76:491 - 5; PMID: 9868840
  • Colnot F, Sureau P, Alexandre JL, Arnaudo JP, Hesse JY, Jeanmaire H. [Post-exposure antirabies vaccination. Early serological response to vaccine cultivated on VERO cells using a reduced 2-1-1 schedule]. Presse Med 1994; 23:1609 - 12; PMID: 7831241
  • Chutivongse S, Wilde H, Fishbein DB, Baer GM, Hemachudha T. One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. Vaccine 1991; 9:573 - 6; http://dx.doi.org/10.1016/0264-410X(91)90244-Z; PMID: 1771970
  • Vodopija R, Lafont M, Baklaić Z, Ljubicić M, Svjetlicić M, Vodopija I. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 1997; 15:571 - 4; http://dx.doi.org/10.1016/S0264-410X(97)00207-7; PMID: 9160527
  • Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, Cao Q, Liu B, Pan H, Wang M. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin 2011; 7:220 - 4; http://dx.doi.org/10.4161/hv.7.2.14003; PMID: 21311216
  • Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82:425 - 35; PMID: 18064757
  • Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine 2009; 27:7141 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.09.029; PMID: 19925944
  • Warrell MJ, Warrell DA, Suntharasamai P, Viravan C, Sinhaseni A, Udomsakdi D, Phanfung R, Xueref C, Vincent-Falquet JC, Nicholson KG, et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancet 1983; 2:301 - 4; http://dx.doi.org/10.1016/S0140-6736(83)90288-X; PMID: 6135830
  • Warrell MJ, Suntharasamai P, Nicholson KG, Warrell DA, Chanthavanich P, Viravan C, Sinhaseni A, Phanfung R, Xueref C, Vincent-Falquet JC. Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens. Lancet 1984; 1:874 - 6; http://dx.doi.org/10.1016/S0140-6736(84)91340-0; PMID: 6143187
  • Dodet B, Asian Rabies Expert Bureau. Preventing the incurable: Asian rabies experts advocate rabies control. Vaccine 2006; 24:3045 - 9; http://dx.doi.org/10.1016/j.vaccine.2005.10.015; PMID: 16652450
  • Hampson K, Cleaveland S, Briggs D. Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries. PLoS Negl Trop Dis 2011; 5:e982; http://dx.doi.org/10.1371/journal.pntd.0000982; PMID: 21408121
  • Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, Lohsoonthorn V, Khawplod P, Tantawichien T. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010; 50:56 - 60; http://dx.doi.org/10.1086/649211; PMID: 19995217
  • Chuan-lin W, Xiao-wei Z, Yong-xin Y. Study on the Compliance and Economic Cost of Rabies Vaccination. Chinese Journal of Vaccines and Immunization 2010; 3:254 - 7
  • Fu C, He Q, Xu J, Xie H, Ding P, Hu W, Dong Z, Liu X, Wang M. Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine 2012; 31:154 - 8; http://dx.doi.org/10.1016/j.vaccine.2012.10.078; PMID: 23127516
  • Yu PC, Lv XJ, Shen XX, Cao L, Zheng XX, Shan H, Tang Q. [The establishment of a rapid fluorescent focus inhibition test for testing rabies virus neutralizing antibody]. Zhonghua Liu Xing Bing Xue Za Zhi 2010; 31:438 - 41; PMID: 20513292
  • Yu PC, Noguchi A, Inoue S, Tang Q, Rayner S, Liang GD. Comparison of RFFIT tests with different standard sera and testing procedures. Virol Sin 2012; 27:187 - 93; http://dx.doi.org/10.1007/s12250-012-3247-8; PMID: 22684473

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.